Skip to main content
Dennis Hickstein, MD, Oncology, Bethesda, MD

DennisDurandHicksteinMD

Oncology Bethesda, MD

Hematologic Oncology

Physician

Dr. Hickstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hickstein's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1983 - 1987
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Internal Medicine, 1978 - 1981
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 1978

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1982 - 2025
  • MI State Medical License
    MI State Medical License 1979 - 1984
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1994

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Article Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency  
    Dennis D Hickstein, Ashish Kumar, Suhag H Parikh, Raif S Geha, ScienceDirect

Abstracts/Posters

  • Single-Cell RNA Sequencing Reveals a Distinct Transcriptome Signature of Hematopoiesis in GATA2 Deficiency
    Dennis D. Hickstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • CRISPR-Cas9 Fusion to Dominant-Negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target Sites
    CRISPR-Cas9 Fusion to Dominant-Negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target SitesJune 28th, 2020
  • Gene Defect Predisposes People to Leukemia
    Gene Defect Predisposes People to LeukemiaSeptember 5th, 2011

Grant Support

  • Allotransplant For DOCK8 DeficiencyNational Cancer Institute2011
  • Zebrafish Models Of CancerNational Cancer Institute2010–2011
  • Hematopoietic Stem Cell Transplant For Immunodeficiency With MDSNational Cancer Institute2010–2011
  • Hematopoietic Stem Cell Gene Therapy For Leukocyte Adhesion DeficiencyNational Cancer Institute2010–2011
  • Hematopoietic Stem Cell Gene Therapy For Leukocyte Adhesion DeficiencyDivision Of Clinical Sciences - Nci2009
  • Zebrafish Models Of CancerDivision Of Basic Sciences - Nci2009
  • Hematopoietic Stem Cell Transplant For Immunodeficiency With MDSDivision Of Basic Sciences - Nci2009
  • Zebrafish Models Of CancerNational Cancer Institute2008
  • Hematopoietic Stem Cell Transplant For Immunodeficiency With MDSNational Cancer Institute2008
  • Hematopoietic Stem Cell Gene Therapy For Leukocyte Adhesion DeficiencyNational Cancer Institute2007–2008
  • Zebrafish Models Of Human Leukemia And SarcomaNational Cancer Institute2007
  • Zebrafish Models Of Human Leukemia And SarcomaDivision Of Basic Sciences - Nci2005–2006
  • Hematopoietic Stem Cell Gene Therapy For Leukocyte AdhesDivision Of Clinical Sciences - Nci2002–2006